References
- Grimsby J Chen K Wang LJ Lan NC Shih JC . Human monoamine oxidase A and B genes exhibit identical exon-intron organization . Proc. Natl Acad. Sci. USA88 ( 9 ), 3637 – 3641 ( 1991 ).
- Hsiao JK Potter WZ Agren H Owen RR Pickar D . Clinical investigation of monoamine neurotransmitter interactions . Psychopharmacology112 ( 1 Suppl. ), S76 – S84 ( 1993 ).
- Kurian MA Gissen P Smith M Heales SJR Clayton PT . The monoamine neurotransmitter disorders: an expanding range of neurological syndromes . Lancet Neurol.10 ( 8 ), 721 – 733 ( 2011 ).
- Entzeroth M Ratty AK . Monoamine oxidase inhibitors – revisiting a therapeutic principle . Open J. Depress.06 ( 02 ), 31 – 68 ( 2017 ).
- Hasegawa K Kimura T Miyashita Y Funatsu K . Nonlinear partial least squares modeling of phenyl alkylamines with the monoamine oxidase inhibitory activities . J. Chem. Inf. Comput. Sci.36 ( 5 ), 1025 – 1029 ( 1996 ).
- Medvedev AE Veselovsky AV Shvedov VI et al. Inhibition of monoamine oxidase by pirlindole analogues: 3D-QSAR and CoMFA analysis . J. Chem. Inf. Comput. Sci.38 ( 6 ), 1137 – 1144 ( 1998 ).
- Morón JA Campillo M Perez V Unzeta M Pardo L . Molecular determinants of MAO selectivity in a series of indolylmethylamine derivatives: biological activities, 3D-QSAR/CoMFA analysis, and computational simulation of ligand recognition . J. Med. Chem.43 ( 9 ), 1684 – 1691 ( 2000 ).
- Catto M Nicolotti O Leonetti F et al. Structural insights into monoamine oxidase inhibitory potency and selectivity of 7-substituted coumarins from ligand- and target-based approaches . J. Med. Chem.49 ( 16 ), 4912 – 4925 ( 2006 ).
- Santana L Uriarte E Gonzalez-Diaz H Zagotto G Soto-Otero R Mendez-Alvarez E . A QSAR model for in silico screening of MAO-A inhibitors. Prediction, synthesis, and biological assay of novel coumarins . J. Med. Chem.49 ( 3 ), 1149 – 1156 ( 2006 ).
- Mladenovic M Patsilinakos A Pirolli A Sabatino M Ragno R . Understanding the molecular determinant of reversible human monoamine oxidase B inhibitors containing 2H-chromen-2-one core: structure-based and ligand-based derived three-dimensional quantitative structure–activity relationships predictive models . J. Chem. Inf. Model57 ( 4 ), 787 – 814 ( 2017 ).
- Mangiatordi GF Alberga D Pisani L et al. A rational approach to elucidate human monoamine oxidase molecular selectivity . Eur. J. Pharm. Sci.101 , 90 – 99 ( 2017 ).
- Reis J Manzella N Cagide F et al. Tight-binding inhibition of human monoamine oxidase B by chromone analogs: a kinetic, crystallographic, and biological analysis . J. Med. Chem.61 ( 9 ), 4203 – 4212 ( 2018 ).
- De Monte C Carradori S Chimenti P et al. New insights into the biological properties of Crocus sativus L.: chemical modifications, human monoamine oxidases inhibition and molecular modeling studies . Eur. J. Med. Chem.82 , 164 – 171 ( 2014 ).
- Turkmenoglu FP Baysal I Ciftci-Yabanoglu S et al. Flavonoids from Sideritis species: human monoamine oxidase (hMAO) inhibitory activities, molecular docking studies and crystal structure of xanthomicrol . Molecules20 ( 5 ), 7454 – 7473 ( 2015 ).
- Blair HA Dhillon S . Safinamide: a review in Parkinson's disease . CNS Drugs31 ( 2 ), 169 – 176 ( 2017 ).
- Gaulton A Hersey A Nowotka M et al. The ChEMBL database in 2017 . Nucleic Acids Res.45 ( D1 ), D945 – D954 ( 2017 ).
- BIOVIA pipeline pilot . www.3dsbiovia.com/products/collaborative-science/biovia-pipeline-pilot/ .
- Helguera AM Perez-Garrido A Gaspar A et al. Combining QSAR classification models for predictive modeling of human monoamine oxidase inhibitors . Eur. J. Med. Chem.59 , 75 – 90 ( 2013 ).
- Cousins KR . Computer review of ChemDraw Ultra 12.0 . J. Am. Chem. Soc.133 ( 21 ), 8388 ( 2011 ).
- Deng ZL Du CX Li X et al. Exploring the biologically relevant chemical space for drug discovery . J. Chem. Inf. Model53 ( 11 ), 2820 – 2828 ( 2013 ).
- He SB Ben H Kuang ZK Wang D Kong DX . Predicting subtype selectivity for adenosine receptor ligands with three-dimensional biologically relevant spectrum (BRS-3D) . Sci. Rep.6 , 36595 ( 2016 ).
- Hu B Kuang ZK Feng SY Wang D He SB Kong DX . Three-dimensional biologically relevant spectrum (BRS-3D): shape similarity profile based on PDB ligands as molecular descriptors . Molecules21 ( 11 ), 1554 ( 2016 ).
- Kuang ZK Feng SY Hu B Wang D He SB Kong DX . Predicting subtype selectivity of dopamine receptor ligands with three-dimensional biologically relevant spectrum . Chem. Biol. Drug Des.88 ( 6 ), 859 – 872 ( 2016 ).
- Han LY Ma XH Lin HH et al. A support vector machines approach for virtual screening of active compounds of single and multiple mechanisms from large libraries at an improved hit-rate and enrichment factor . J. Mol. Graph. Model.26 ( 8 ), 1276 – 1286 ( 2008 ).
- Goodarzi M Heyden YV Funar-Timofei S . Towards better understanding of feature-selection or reduction techniques for quantitative structure–activity relationship models . Trac. Trend. Anal. Chem.42 , 49 – 63 ( 2013 ).
- Netzeva TI Worth A Aldenberg T et al. Current status of methods for defining the applicability domain of (quantitative) structure–activity relationships. The report and recommendations of ECVAM Workshop 52 . Altern. Lab. Anim.33 ( 2 ), 155 – 173 ( 2005 ).
- Consonni V Ballabio D Todeschini R . Comments on the definition of the Q2 parameter for QSAR validation . J. Chem. Inf. Model.49 ( 7 ), 1669 – 1678 ( 2009 ).
- Liu Y . A comparative study on feature selection methods for drug discovery . J. Chem. Inf. Comput. Sci.44 ( 5 ), 1823 – 1828 ( 2004 ).
- Sterling T Irwin JJ . ZINC 15–ligand discovery for everyone . J. Chem. Inf. Model.55 ( 11 ), 2324 – 2337 ( 2015 ).